CLINICAL_TRIALS
trial_result
· 2014-09-09
Clinical Trial Update: Intravitreal Aflibercept Injection in Vision Impairment Due to DME [Phase 3]
Summary
Phase 3 trial update for intravitreal aflibercept in vision impairment due to diabetic macular edema (DME) has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Diabetes Mellitus, Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2014-09-09